Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400618 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Gints Kalnins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Latvian Biomedical Research and Study Centre, Ratsupites 1 k-1, LV1067, Riga, Latvia. Hauptthemen laut MEDLINE: SARS-CoV-2, Methyltransferases, Viral Nonstructural Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Economics of the Republic of Latvia, "State research project in the field of biomedicine, medical technologies and pharmacy", HZB BESSY II.
Abstract (Originalsprache)
Coronaviruses, including SARS‐CoV‐2, possess an mRNA 5′ capping apparatus capable of mimicking the natural eukaryotic capping signature. Two SAM‐dependent methylating enzymes play important roles in this process: nsp14 methylates the N7 of the guanosine cap, and nsp16‐nsp10 methylates the 2′‐O‐ of subsequent nucleotides of viral mRNA. The 2′‐O‐methylation performed by nsp16‐nsp10 is crucial for the escape of the viral RNA from innate immunity. Inhibition of this enzymatic activity has been proposed as a way to combat coronaviruses. In this study, we employed X‐ray crystallography to analyze the binding of the SAM analogues to the active site of nsp16‐nsp10. We obtained eleven 3D crystal structures of the nsp16‐nsp10 complexes with SAM‐derived inhibitors, demonstrated different conformations of the methionine substituting part of the molecules, and confirmed that simultaneous dual‐site targeting of both SAM and RNA sites correlates with higher inhibitory potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Latvian Biomedical Research and Study Centre, Ratsupites 1 k-1, LV1067, Riga, Latvia.
- Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga, LV1006, Latvia.
- University of Latvia, Jelgavas 1, LV1004, Riga, Latvia.
ORCID-Profile: Raitis Bobrovs
Förderung
- Ministry of Economics of the Republic of Latvia
- "State research project in the field of biomedicine, medical technologies and pharmacy"
- HZB BESSY II
- DIAMOND Light Source
Zitieren
APA
Kalnins, G., Rudusa, L., Bula, A. L., Zelencova-Gopejenko, D., Bobileva, O., Sisovs, M., Tars, K., Jirgensons, A., Jaudzems, K., & Bobrovs, R. (2024). Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202400618
Vancouver
Kalnins G, Rudusa L, Bula AL, Zelencova-Gopejenko D, Bobileva O, Sisovs M, et al. Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors. ChemMedChem. 2024. doi:10.1002/cmdc.202400618
BibTeX
@article{Kalnins2024,
author = {Kalnins, Gints and Rudusa, Laura and Bula, Anna L and Zelencova-Gopejenko, Diana and Bobileva, Olga and Sisovs, Mihails and Tars, Kaspars and Jirgensons, Aigars and Jaudzems, Kristaps and Bobrovs, Raitis},
title = {Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400618}
}
EUVIMED